Skip to main content
Equibles

UBS Group AG

Position in BIIB — Biogen Inc.

CIK 1610520 ZURICH, V8
Back to BIIB Full portfolio

Position in BIIB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$222,574,206
+$126,610,121 QoQ
Shares Held
1,030,150
+96.8% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#24
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Derivatives in BIIB

reported options exposure · as of Jun 30, 2026
CallValue
$108,289,272
CallShares
501,200
PutValue
$432,120
PutShares
2,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. BIIB ranks #10 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 3,865,931 $4,636,914,000
2 ABBV
AbbVie Inc.
 12,845,120 $3,232,345,993
3 JNJ
Johnson & Johnson
 11,036,891 $2,803,039,201
4 MRK
Merck & Co., Inc.
 13,744,783 $1,766,204,613
5 AMGN
Amgen Inc
 3,308,695 $1,198,144,628
6 AZN
Astrazeneca PLC
 5,297,462 $1,004,504,738
7 GILD
Gilead Sciences, Inc.
 4,503,294 $568,946,162
8 BMY
Bristol Myers Squibb Co
 8,876,439 $511,460,413

All Filings in BIIB

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $108,289,272 501,200
2026-06-30 $432,120 2,000
2026-06-30 $222,574,206 1,030,150
2026-03-31 $366,660 2,000
2026-03-31 $95,964,085 523,450
2026-03-31 $219,996 1,200
2025-12-31 $112,948,265 641,788
2025-12-31 $13,463,235 76,500
2025-12-31 $8,570,713 48,700
2025-09-30 $9,609,488 68,600
2025-09-30 $6,471,696 46,200
2025-09-30 $89,506,214 638,965
2025-06-30 $8,427,089 67,100
2025-06-30 $5,676,668 45,200
2025-06-30 $55,973,451 445,684
2025-03-31 $13,547,160 99,000
2025-03-31 $88,418,752 646,147
2025-03-31 $9,784,060 71,500
2024-12-31 $19,543,176 127,800
2024-12-31 $45,417,240 297,000
2024-12-31 $160,324,231 1,048,419
2024-09-30 $97,666,860 503,853
2024-09-30 $23,512,792 121,300
2024-09-30 $30,723,640 158,500
2024-06-30 $104,901,096 452,511
2024-06-30 $24,804,740 107,000
2024-06-30 $36,836,198 158,900
2024-03-31 $37,260,864 172,800
2024-03-31 $32,689,508 151,600
2024-03-31 $102,602,355 475,826
2023-12-31 $53,668,898 207,400
2023-12-31 $87,555,859 338,354
2023-12-31 $67,150,815 259,500
2023-09-30 $49,037,508 190,800
2023-09-30 $107,892,281 419,798
2023-09-30 $68,338,959 265,900
2023-06-30 $111,869,707 392,732
2023-06-30 $22,189,815 77,900
2023-06-30 $41,929,920 147,200
2023-03-31 $19,851,342 71,400
2023-03-31 $82,320,231 296,084
2023-03-31 $37,812,080 136,000
2022-12-31 $81,490,631 294,275
2022-12-31 $46,162,564 166,700
2022-12-31 $12,322,940 44,500
2022-09-30 $40,744,200 152,600
2022-09-30 $39,200,139 146,817
2022-09-30 $7,281,090 27,270
2022-06-30 $27,552,294 135,100
2022-06-30 $5,547,168 27,200

Report a Problem

Category
Description
Email (optional, for follow-up)